Carlos A.M. Campos

Showing 1-10 of 10 articles

Author Bruno L. Janella

Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores

Janella B, Campos C, Caixeta A, Almeida B, Sandoli de Brito Jr F, Abizaid A, Perin M

November 20, 2017 | 10.4244/EIJ-D-16-00659

Author Hiroki Tateishi

Interventions for valvular disease

The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique

Tateishi H, Abdelghani M, Cavalcante R, Miyazaki Y, Campos C, Collet C, Slots T, Leite R, Mangione J, Abizaid A, Soliman O, Spitzer E, Onuma Y, Serruys P, Lemos P, de Brito Jr F

May 15, 2017 | 10.4244/EIJ-D-16-00647

Author Javier Escaned

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein AP, Taggart D, Morel M-A, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Author Hiroki Tateishi

Interventions for valvular disease

Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry

Tateishi H, Campos C, Abdelghani M, Leite R, Mangione J, Bary L, Soliman O, Spitzer E, Perin M, Onuma Y, Serruys P, Lemos P, Brito F

March 18, 2016 | 10.4244/EIJV11I12A271

Author Philippe Généreux

Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index

Généreux P, Campos C, Yadav M, Palmerini T, Caixeta A, Xu K, Francese D, Dangas G, Mehran R, Leon M, Serruys P, Stone G

October 20, 2015 | 10.4244/EIJY14M10_05

Author Carlos A.M. Campos

Coronary interventions

The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation

Campos C, Christiansen E, Stone G, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA26

Author Yao-Jun Zhang

Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

Zhang Y-J, Bourantas C, Muramatsu T, Iqbal J, Farooq V, Diletti R, Campos C, Onuma Y, Garcia-Garcia H, Serruys P

October 20, 2014 | 10.4244/EIJV10I6A118

Author Expedito Ribeiro

First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial

Ribeiro E, Campos C, Ribeiro H, Lopes A, Esper R, Meireles G, Perin M, Abizaid A, Lemos P

April 22, 2014 | 10.4244/EIJV9I12A234

Author Christos Bourantas

Transcatheter aortic valve update 2013

Bourantas C, Van Mieghem N, Soliman O, Campos C, Iqbal J, Serruys P

September 15, 2013 | 10.4244/EIJV9SSA16

Author Pedro Alves Lemos

Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention

Lemos P, Campos C, FalcÃ£o J, Ribeiro E, Perin M, Kajita L, Filho E, da Gama M, Horta P, Marchiori G, Spadaro A, Martinez E

June 30, 2009 | 10.4244/EIJV5I2A37

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke